Literature DB >> 1567368

Characterization of a family of structurally related glycoproteins expressing beta 1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells.

S Laferté1, L C Loh.   

Abstract

Previous studies have established that metastatic tumour cells express high levels of beta 1-6-branched Asn-linked oligosaccharides which can be detected with the lectin leucoagglutinin (L-PHA) [Dennis, Laferté, Waghorne, Breitman & Kerbel (1987) Science 236, 582-585]. In order to identify L-PHA-binding glycoproteins which may play a role specifically in colon cancer, we have prepared monoclonal antibodies (MAbs) to the moderately well-differentiated human colon carcinoma cell line HT29. In this paper we present the initial characterization of a family of structurally related L-PHA-binding glycoproteins detected by MAb 1H9 which are differentially expressed and processed by HT29 cells and by two other human colon carcinoma cell lines, SW480 and SW620. In contrast to HT29, the SW480 and SW620 cell lines were established from a poorly differentiated grade III/IV primary tumour and one of its lymph node metastases respectively. MAb 1H9 detects in HT29 cells a conformational determinant present on three L-PHA-binding glycoproteins of 100, 70 and 25kDa, as well as a 74 kDa glycoprotein with high-mannose-type Asn-linked oligosaccharides. Pulse-chase experiments and peptide mapping analyses revealed that the 74 kDa and 100 kDa species are related by carbohydrate processing and are probably derived from a common 76 kDa precursor. On the other hand, the 70 kDa glycoprotein is synthesized from an endoglycosidase H-sensitive precursor of 56 kDa which is structurally related to, but distinct from, the aforementioned 76 kDa precursor. In addition, the 100 kDa species is secreted into the culture medium, whereas the 70 kDa glycoprotein is retained intracellularly. SW480 and SW620 cells showed qualitative and quantitative differences from HT29 cells, including increased secretion of a smaller L-PHA-binding glycoprotein of 92 kDa into the culture medium, as well as apparent differences in glycosylation of the intracellular 66 kDa glycoprotein. These results suggested that the expression, glycosylation and subcellular localization of this family of L-PHA-binding glycoproteins may correlate with the differentiation status of colon cancer cells and/or reflect biochemical changes. characteristic of more progressive metastatic tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567368      PMCID: PMC1131014          DOI: 10.1042/bj2830193

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Glycobiology.

Authors:  T W Rademacher; R B Parekh; R A Dwek
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 2.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Granulocytic differentiation of HL-60 cells is associated with increase of poly-N-acetyllactosamine in Asn-linked oligosaccharides attached to human lysosomal membrane glycoproteins.

Authors:  N Lee; W C Wang; M Fukuda
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

4.  Endo-beta-D-galactosidases of Bacteroides fragilis and Escherichia freundii hydrolyze linear but not branched oligosaccharide domains of glycolipids of the neolacto series.

Authors:  P Scudder; P Hanfland; K Uemura; T Feizi
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

5.  Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.

Authors:  L C Loh
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

6.  Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells.

Authors:  J W Dennis; S Laferté
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Inhibition of human HT29 colon carcinoma growth in vitro and in vivo by swainsonine and human interferon-alpha 2.

Authors:  J W Dennis; K Koch; D Beckner
Journal:  J Natl Cancer Inst       Date:  1989-07-05       Impact factor: 13.506

Review 8.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

9.  Differentiation-associated decrease in the proportion of fucosylated polylactosaminoglycans of CaCo-2 human colonic adenocarcinoma cells.

Authors:  A Youakim; A Herscovics
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

10.  Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen.

Authors:  J W Dennis; C A Waller; V Schirrmacher
Journal:  J Cell Biol       Date:  1984-10       Impact factor: 10.539

View more
  6 in total

1.  Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas.

Authors:  Motohiro Nonaka; Bruce Yong Ma; Hirotsugu Imaeda; Keiko Kawabe; Nobuko Kawasaki; Keiko Hodohara; Nana Kawasaki; Akira Andoh; Yoshihide Fujiyama; Toshisuke Kawasaki
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Purification and properties of recombinant beta-galactosidase from Bacillus circulans.

Authors:  H Fujimoto; M Miyasato; Y Ito; T Sasaki; K Ajisaka
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  Anticancer Activity of Chloroform Extract and Sub-fractions of Nepeta deflersiana on Human Breast and Lung Cancer Cells: An In vitro Cytotoxicity Assessment.

Authors:  Mai M Al-Oqail; Ebtesam S Al-Sheddi; Maqsood A Siddiqui; Javed Musarrat; Abdulaziz A Al-Khedhairy; Nida N Farshori
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

4.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

Review 5.  Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target.

Authors:  Emily Capone; Stefano Iacobelli; Gianluca Sala
Journal:  J Transl Med       Date:  2021-09-26       Impact factor: 5.531

6.  Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells.

Authors:  J J Wang; Y F Chang; Y T Chern; C W Chi
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.